Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis

Xiaolong Tang(Shenzhen University Health Science Center), Baohua Liu(Shenzhen University), Guo Li(Cincinnati Children's Hospital Medical Center), Fengting Su(Universität Innsbruck), Zuojun Liu(Shenzhen University Health Science Center), Ji Li(Sichuan University), Lei Shi(Sun Yat-sen University), Minxian Qian(China Pharmaceutical University), Shimin Sun(Shandong University of Technology), Meng Yuan(Ministry of Education of the People's Republic of China)
Nature Communications
August 25, 2021
10.1038/s41467-021-25274-3
Cited by 56

Related Papers

Genomic instability in laminopathy-based premature aging
|Nature Medicine|2005|641
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
|Cell Reports|2020|450
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
|Science|2021|409
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
|Cell|2020|387
Lateral Sharpening of Cortical Frequency Tuning by Approximately Balanced Inhibition
|Neuron|2008|291